December 9, 2019
Inceptua, Onconova Therapeutics in pre-approval access collaboration
Inceptua Medicines Access, a business unit of the Inceptua Group, has announced the collaboration with Onconova Therapeutics to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.